Olema Oncology, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
7.56
+0.04 (0.53%)
At close: Nov 13, 2026, 4:00 PM EST
7.53
-0.03 (-0.40%)
After-hours: Nov 13, 2026, 7:37 PM EST
Olema Oncology Market Cap
Olema Oncology has a market cap or net worth of $662.3 million as of November 13, 2026. It is the 12,498th most valuable company in the world and the 2,517th biggest in the United States. Its market cap has increased by 19.68% in one year.
Market Cap
662.30M
Enterprise Value
251.89M
1-Year Change
19.68%
Global Rank
Country Rank
#2,517 United States
Category
ChartMarket Cap Chart
Since the IPO on November 19, 2020, Olema Oncology's market cap has decreased from $1.79B to $662.30M, a decrease of -63.09%. That is a compound annual growth rate of -15.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 662.30M | -66.32% |
| Dec 31, 2025 | 1.97B | 357.26% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Achieve Life Sciences | 695.42M |
| Attovia Therapeutics | 690.70M |
| 4D Molecular Therapeutics | 689.52M |
| Adlai Nortye Group | 683.26M |
| DBV Technologies | 682.01M |
| ArriVent BioPharma | 672.92M |
| Design Therapeutics | 670.46M |
| Cullinan Therapeutics | 667.39M |